Show simple item record

Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination : a New Diagnostic Dilemma

dc.contributor.authorashoor, arwa
dc.contributor.authorShephard, Julie
dc.contributor.authorLissidini, Germana
dc.contributor.authorNicosia, Luca
dc.date.accessioned2024-10-03T11:02:55Z
dc.date.available2024-10-03T11:02:55Z
dc.date.issued2022-05-31
dc.identifier.citationAshoor A, Shephard J, Lissidini G, Nicosia L. Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma. Korean J Radiol. 2022 Jul;23(7):775-776. doi: 10.3348/kjr.2022.0207. Epub 2022 May 31en_US
dc.identifier.urihttp://hdl.handle.net/20.500.14200/6019
dc.description.abstractNo abstract available.en_US
dc.language.isoenen_US
dc.publisherKorean Society of Radiologyen_US
dc.subjectSurgeryen_US
dc.subjectRadiologyen_US
dc.titleResponse to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination : a New Diagnostic Dilemmaen_US
dc.typeCorrespondenceen_US
dc.source.journaltitleKorean Journal of Radiologyen_US
rioxxterms.versionNAen_US
dc.contributor.trustauthorAshoor, Arwa
dc.contributor.trustauthorShephard, Julie
dc.contributor.departmentBreast Surgeryen_US
dc.contributor.departmentBreast Radiologyen_US
dc.contributor.roleMedical and Dentalen_US
dc.contributor.affiliationSandwell and West Birmingham NHS Trust; European Institute of Oncologyen_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record